Premium
Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the generics business of UK-based Mallinckrodt Plc in what could have been the biggest overseas acquisition by an Indian pharmaceutical company.The Indian company pulled out possibly because it would have faced several challenges to clinch the deal, two ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
